IL102633A0 - Compositions - Google Patents

Compositions

Info

Publication number
IL102633A0
IL102633A0 IL102633A IL10263392A IL102633A0 IL 102633 A0 IL102633 A0 IL 102633A0 IL 102633 A IL102633 A IL 102633A IL 10263392 A IL10263392 A IL 10263392A IL 102633 A0 IL102633 A0 IL 102633A0
Authority
IL
Israel
Prior art keywords
hlb surfactant
microemulsions
emulsifying
iii
aqueous
Prior art date
Application number
IL102633A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24959558&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL102633(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL102633A0 publication Critical patent/IL102633A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL102633A 1991-07-26 1992-07-24 Compositions IL102633A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73635491A 1991-07-26 1991-07-26

Publications (1)

Publication Number Publication Date
IL102633A0 true IL102633A0 (en) 1993-01-14

Family

ID=24959558

Family Applications (1)

Application Number Title Priority Date Filing Date
IL102633A IL102633A0 (en) 1991-07-26 1992-07-24 Compositions

Country Status (15)

Country Link
EP (1) EP0597007B1 (xx)
JP (1) JPH06509796A (xx)
AT (1) ATE144137T1 (xx)
AU (1) AU667316B2 (xx)
CA (1) CA2114141A1 (xx)
DE (1) DE69214652T2 (xx)
DK (1) DK0597007T3 (xx)
ES (1) ES2093269T3 (xx)
GR (1) GR3022260T3 (xx)
IL (1) IL102633A0 (xx)
MX (1) MX9204379A (xx)
NZ (1) NZ243703A (xx)
PT (1) PT100726A (xx)
WO (1) WO1993002664A1 (xx)
ZA (1) ZA925581B (xx)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183099T1 (de) * 1991-04-19 1999-08-15 Lds Technologies Inc Konvertierbare mikroemulsionsverbindungen
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
NZ243721A (en) * 1991-07-26 1994-11-25 Smithkline Beecham Corp Self-emulsifying microemulsion comprising water soluble drug, high hlb surfactant and a lipophilic phase containing fatty acid triglyceride and a low hlb surfactant
DE69329430T2 (de) * 1992-10-16 2001-05-10 Ibah Inc Konvertierbare mikroemulsionsformulierungen
JPH08502490A (ja) * 1992-10-16 1996-03-19 スミスクライン・ビーチャム・コーポレイション 組成物
JPH08502492A (ja) * 1992-10-16 1996-03-19 スミスクライン・ビーチャム・コーポレイション 治療用ミクロエマルジョン
JPH08507078A (ja) * 1993-02-17 1996-07-30 スミスクライン・ビーチャム・コーポレイション 治療用ペプチド含有のミクロエマルジョン
AU686149B2 (en) * 1993-04-19 1998-02-05 Institute For Advanced Skin Research Inc. Microemulsion preparation containing difficultly absorbable substance
DE69418717D1 (de) * 1993-09-29 1999-07-01 Technobiochip Duenne proteinschichten und zusammensetzungen zu ihrer herstellung
AU692506B2 (en) * 1993-11-17 1998-06-11 Ibah, Inc. Transparent liquid for encapsulated drug delivery
ES2270426T3 (es) * 1994-03-18 2007-04-01 Supernus Pharmaceuticals, Inc. Sistema de suministros de farmacos emulsionados.
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
SE9503143D0 (sv) 1995-09-12 1995-09-12 Astra Ab New preparation
GB9613858D0 (en) * 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
TWI241915B (en) * 1998-05-11 2005-10-21 Ciba Sc Holding Ag A method of preparing a pharmaceutical end formulation using a nanodispersion
US6242001B1 (en) * 1998-11-30 2001-06-05 Mcneil-Ppc, Inc. Method for producing dispersible sterol and stanol compounds
EP1137431A1 (en) * 1998-12-04 2001-10-04 Provalis UK Limited Pharmaceutical compositions containing insulin
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
JP2005515197A (ja) 2001-12-03 2005-05-26 ドー バイオファーマ インコーポレイテッド 安定化された逆ミセル組成物およびその使用
IL162496A0 (en) 2001-12-14 2005-11-20 Jagotec Ag Pharmaceutical compositions containing cyclosporin
US20050232974A1 (en) * 2004-04-19 2005-10-20 Gore Makarand P System and a method for pharmaceutical dosage preparation using jettable microemulsions
EP2626368B1 (en) 2004-07-19 2016-12-21 Biocon Limited Insulin-oligomer conjugates, formulations and uses thereof
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
EP2985026B1 (en) 2005-04-15 2022-08-03 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
ITMI20060618A1 (it) * 2006-03-31 2007-10-01 Enitecnologie Spa Procedimento per la preparazione di nanoemulsioni acqua ion olio e olio in acqua
EP1961412A1 (en) * 2006-12-27 2008-08-27 LEK Pharmaceuticals D.D. Self-microemulsifying drug delivery systems
EP2164466A1 (en) * 2007-06-01 2010-03-24 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
JP5156458B2 (ja) * 2008-03-31 2013-03-06 理研ビタミン株式会社 ソフトカプセル充填用液状組成物
WO2009041105A1 (ja) * 2007-09-27 2009-04-02 Riken Vitamin Co., Ltd. ソフトカプセル充填用液状組成物
RU2453332C2 (ru) 2007-10-16 2012-06-20 Байокон Лимитид Твердая фармацевтическая композиция (варианты) и способ контроля концентрации глюкозы с ее помощью, способ получения твердой фармацевтической композиции (варианты), таблетка (варианты) и способ получения амфорных частиц
AU2009226910B2 (en) 2008-03-18 2014-02-06 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011004395A1 (en) * 2009-07-06 2011-01-13 Intas Biopharmaceuticals Limited Microemulsion formulation for biologicals
AU2010335654B2 (en) * 2009-12-22 2015-04-09 Leo Pharma A/S Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
US20120058187A1 (en) * 2010-09-03 2012-03-08 Novagali Pharma Sa Water-in-oil type emulsion for treating a disease of the eye
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
GB201107629D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Hydrophobic preparations
GB201107630D0 (en) * 2011-05-06 2011-06-22 Proxima Concepts Ltd Microemulsions
AU2013247047A1 (en) 2012-04-11 2014-10-23 Novo Nordisk A/S Insulin formulations
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
BR112019011761A2 (pt) 2016-12-16 2019-11-05 Novo Nordisk As composições farmacêuticas contendo insulina

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1080994A (en) * 1963-10-25 1967-08-31 Nat Res Dev Injectable emulsions containing antigens
US4840660A (en) * 1985-12-30 1989-06-20 Rhone Poulenc Nederlands B.V. Plant growth regulator dispersions
IE60024B1 (en) * 1987-02-03 1994-05-18 Stiefel Laboratories Ltd Microemulsions
NZ243721A (en) * 1991-07-26 1994-11-25 Smithkline Beecham Corp Self-emulsifying microemulsion comprising water soluble drug, high hlb surfactant and a lipophilic phase containing fatty acid triglyceride and a low hlb surfactant

Also Published As

Publication number Publication date
EP0597007B1 (en) 1996-10-16
PT100726A (pt) 1993-09-30
CA2114141A1 (en) 1993-02-18
DE69214652D1 (de) 1996-11-21
DE69214652T2 (de) 1997-03-20
DK0597007T3 (da) 1996-11-18
ES2093269T3 (es) 1996-12-16
WO1993002664A1 (en) 1993-02-18
EP0597007A1 (en) 1994-05-18
MX9204379A (es) 1993-02-01
GR3022260T3 (en) 1997-04-30
JPH06509796A (ja) 1994-11-02
AU667316B2 (en) 1996-03-21
AU2411592A (en) 1993-03-02
ATE144137T1 (de) 1996-11-15
ZA925581B (en) 1993-05-14
NZ243703A (en) 1995-12-21

Similar Documents

Publication Publication Date Title
IL102633A0 (en) Compositions
MX9204382A (es) Composiciones
DE69403057D1 (de) Zusammensetzung, die bei peroraler verabreichung eine mikroemulsion bildet
KR100666016B1 (ko) 테스토스테론 운데카노에이트 및 피마자유를 포함하는 제제
ZA966067B (en) New pharmaceutical dosage formulations of fenofibrate and their applications
EP0375827A3 (en) A disinfectant composition for medical use
CA2072509A1 (en) Cyclosporin emulsion compositions for oral administration
GB9616237D0 (en) Aerosol formulations
AP2000001943A0 (en) Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent.
CA2337745A1 (en) Human growth hormone aqueous formulation
GR3034191T3 (en) Formulations for lipophilic compounds
GB9208712D0 (en) Pharmaceutical compositions containing cyclosporin derivates
EP0766960A4 (en) PREPARATIONS FOR EXTERNAL USE FOR THE TREATMENT OF DERMATOS
NZ313899A (en) Oral cyclosporin compositions comprising cyclosporin A, a solvent either ethanol or propylene glycol and one non-ionic polyoxyethylene surfactant selected from polyoxyethylene alcohols and mono-esters of ethoxylated sorbitans
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
CA2195079A1 (en) Aqueous foamable composition